195 related articles for article (PubMed ID: 1086653)
1. Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus sera.
Morito T; Tanimoto K; Hashimoto Y; Horiuchi Y; Juji T
Ann Rheum Dis; 1975 Oct; 35(5):415-21. PubMed ID: 1086653
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Fc-rosette formation by synovial fluids from patients with rheumatoid arthritis.
Hashimoto Y; Morito T; Tanimoto K; Horiuchi Y
Ann Rheum Dis; 1977 Apr; 36(2):170-5. PubMed ID: 857743
[TBL] [Abstract][Full Text] [Related]
3. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
Nakai H; Morito T; Tanimoto K; Horiuchi Y
J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of T gamma rosette formation by the sera from patients with systemic lupus erythematosus. Relation to T gamma-specific antilymphocyte antibody.
Okudaira K; Tanimoto K
Int Arch Allergy Appl Immunol; 1983; 71(4):346-51. PubMed ID: 6602775
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. A method for detection of circulating immune complexes].
Moyito T; Aotsuka S; Yokohari R; Moroi Y; Yokohari R
Ryumachi; 1976 Mar; 16(1):4-11. PubMed ID: 1085992
[No Abstract] [Full Text] [Related]
6. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
Theofilopoulos AN; Dixon FJ; Bokisch VA
J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
[TBL] [Abstract][Full Text] [Related]
7. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
Anderson CL; Stillman WS
J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
[TBL] [Abstract][Full Text] [Related]
8. Effects of immune complexes from SLE patients on human monocyte locomotion and Fc receptor function.
Lukács K; Kávai M; Bányai A; Sonkoly I; Végh E; Szabó G; Szegedi G
Ann Rheum Dis; 1984 Oct; 43(5):729-33. PubMed ID: 6333850
[TBL] [Abstract][Full Text] [Related]
9. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
[TBL] [Abstract][Full Text] [Related]
10. The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.
Soulillou JP; Carpenter CB; d'Apice AJ; Strom TB
J Exp Med; 1976 Feb; 143(2):405-21. PubMed ID: 129499
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
12. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic lymphocyte-dependent antibodies (LDA). Specificity of Fc receptors.
Fournier C; Lesavre P; Bach JF
Transplantation; 1977 Mar; 23(3):239-47. PubMed ID: 324044
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
Starkebaum G; Arend WP
J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ia reactivity in sera from patients with systemic lupus erythematosus.
Okudaira K; Searles RP; Ceuppens JL; Goodwin JS; Williams RC
J Clin Invest; 1982 Jan; 69(1):17-24. PubMed ID: 6947981
[TBL] [Abstract][Full Text] [Related]
16. The ER-rosette inhibition assay as a test for immune complexes.
Sandilands GP; Reid FM; O'Keeffe T; Peel MG
J Immunol Methods; 1980; 36(1):1-11. PubMed ID: 7204992
[TBL] [Abstract][Full Text] [Related]
17. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of complement-dependent lymphocyte rosette formation by sera of patients with chronic glomerulonephritis.
Gluckman JC; Beaufils H; Sanchez F
Clin Exp Immunol; 1976 Nov; 26(2):247-52. PubMed ID: 991456
[TBL] [Abstract][Full Text] [Related]
19. Fc-rosette inhibition by pregnant women's sera and by rabbit anti-beta2-microglobulin.
Morito T; Tanimoto K; Horiuchi Y; Juji T
Int Arch Allergy Appl Immunol; 1978; 56(3):247-55. PubMed ID: 74365
[TBL] [Abstract][Full Text] [Related]
20. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
